| 1LN8 | A:1-120 | CRYSTAL STRUCTURE OF A NEW ISOFORM OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 1.6 A RESOLUTION |
| 1MF4 | A:1-120 | STRUCTURE-BASED DESIGN OF POTENT AND SELECTIVE INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AND A DESIGNED PEPTIDE INHIBITOR AT 1.9 A RESOLUTION |
| 1MH2 | A:1-120; B:1-120 | CRYSTAL STRUCTURE OF A ZINC CONTAINING DIMER OF PHOSPHOLIPASE A2 FROM THE VENOM OF INDIAN COBRA (NAJA NAJA SAGITTIFERA) |
| 1MH7 | A:1-120 | CRYSTAL STRUCTURE OF A CALCIUM-FREE ISOFORM OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 2.0 A RESOLUTION |
| 1MH8 | A:1-120 | CRYSTAL STRUCTURE OF A PHOPHOLIPASE A2 MONOMER WITH ISOLEUCINE AT SECOND POSITION |
| 1OXR | A:1-120 | ASPIRIN INDUCES ITS ANTI-INFLAMMATORY EFFECTS THROUGH ITS SPECIFIC BINDING TO PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND ASPIRIN AT 1.9A RESOLUTION |
| 1S6B | A:1-120; B:1-120 | X-RAY CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN TWO HOMOLOGOUS ISOFORMS OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA: PRINCIPLE OF MOLECULAR ASSOCIATION AND INACTIVATION |
| 1SZ8 | A:1-120 | CRYSTAL STRUCTURE OF AN ACIDIC PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 1.5 A RESOLUTION |
| 1T37 | A:1-120 | DESIGN OF SPECIFIC INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN GROUP I PHOSPHOLIPASE A2 AND A DESIGNED PENTAPEPTIDE LEU-ALA-ILE-TYR-SER AT 2.6A RESOLUTION |
| 1TD7 | A:1-120 | INTERACTIONS OF A SPECIFIC NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) WITH GROUP I PHOSPHOLIPASE A2 (PLA2): CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PLA2 AND NIFLUMIC ACID AT 2.5 A RESOLUTION |
| 1XXW | A:1-120; B:1-120 | STRUCTURE OF ZINC INDUCED HETERODIMER OF TWO CALCIUM FREE ISOFORMS OF PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 2.7A RESOLUTION |
| 1YXL | A:1-120 | CRYSTAL STRUCTURE OF A NOVEL PHOSPHOLIPASE A2 FROM NAJA NAJA SAGITTIFERA AT 1.5 A RESOLUTION |
)
)